First Time Loading...

Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 512.5 JPY 1.41% Market Closed
Updated: Apr 30, 2024

Santen Pharmaceutical Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santen Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Cash from Operating Activities
¥68.1B
CAGR 3-Years
23%
CAGR 5-Years
13%
CAGR 10-Years
13%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Operating Activities
¥731.4B
CAGR 3-Years
-3%
CAGR 5-Years
17%
CAGR 10-Years
13%
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Operating Activities
¥595.3B
CAGR 3-Years
47%
CAGR 5-Years
47%
CAGR 10-Years
25%
Otsuka Holdings Co Ltd
TSE:4578
Cash from Operating Activities
¥283.2B
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Operating Activities
¥409.9B
CAGR 3-Years
26%
CAGR 5-Years
28%
CAGR 10-Years
23%
Astellas Pharma Inc
TSE:4503
Cash from Operating Activities
¥216.1B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
-2%

See Also

What is Santen Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
68.1B JPY

Based on the financial report for Dec 31, 2023, Santen Pharmaceutical Co Ltd's Cash from Operating Activities amounts to 68.1B JPY.

What is Santen Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
13%

Over the last year, the Cash from Operating Activities growth was 57%. The average annual Cash from Operating Activities growth rates for Santen Pharmaceutical Co Ltd have been 23% over the past three years , 13% over the past five years , and 13% over the past ten years .